Managing side effects during dose escalation Gastrointestinal side effects are the most commonly reported adverse events with retatrutide, and they peak during the dose escalation period
Patients who stop at this point typically retain results for 4 to 8 months before drifting back to their untreated trajectory
Research Use Limitation Used solely for in vitro experiments Not permitted for clinical trials involving humans Not permitted for human or veterinary administration Not permitted for investigational human use Independently analysed by Liquilabs s.r.o
Mass calibration and parameter optimization was selected
Universidade Federal de Viosa, Viosa, Minas Gerais State, Brazil Ricaboni D, Mailhe M, Benezech A, Cadoret F, Fournier PE, Raoult D (2017) Acidaminococcus timonensis sp